BlackRock Health Sciences Trust (NYSE:BME) Short Interest Down 15.9% in March

BlackRock Health Sciences Trust (NYSE:BME) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 12,700 shares, a decrease of 15.9% from the February 28th total of 15,100 shares. Based on an average daily trading volume, of 53,600 shares, the days-to-cover ratio is presently 0.2 days.

BlackRock Health Sciences Trust Price Performance

NYSE BME traded down $0.16 during midday trading on Thursday, hitting $38.26. The company had a trading volume of 16,943 shares, compared to its average volume of 39,620. The firm has a 50-day moving average price of $39.80 and a 200-day moving average price of $39.91. BlackRock Health Sciences Trust has a twelve month low of $36.87 and a twelve month high of $42.64.

BlackRock Health Sciences Trust Announces Dividend

The business also recently declared a monthly dividend, which was paid on Monday, March 31st. Investors of record on Friday, March 14th were paid a $0.2621 dividend. This represents a $3.15 dividend on an annualized basis and a yield of 8.22%. The ex-dividend date of this dividend was Friday, March 14th.

Institutional Investors Weigh In On BlackRock Health Sciences Trust

Several institutional investors and hedge funds have recently bought and sold shares of the company. Raymond James Financial Inc. bought a new position in BlackRock Health Sciences Trust in the 4th quarter valued at about $3,250,000. Wolverine Asset Management LLC raised its position in BlackRock Health Sciences Trust by 29.1% during the fourth quarter. Wolverine Asset Management LLC now owns 110,493 shares of the company’s stock valued at $4,191,000 after purchasing an additional 24,928 shares in the last quarter. AlphaStar Capital Management LLC acquired a new position in BlackRock Health Sciences Trust during the fourth quarter valued at approximately $878,000. Hara Capital LLC bought a new stake in BlackRock Health Sciences Trust during the fourth quarter worth $832,000. Finally, Invesco Ltd. boosted its holdings in shares of BlackRock Health Sciences Trust by 8.9% in the 4th quarter. Invesco Ltd. now owns 223,316 shares of the company’s stock valued at $8,470,000 after purchasing an additional 18,213 shares in the last quarter.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.